ENH Antibody, ENH1 Antibody, Enigma homolog Antibody, Enigma like LIM domain protein Antibody, Enigma like PDZ and LIM domains protein Antibody, Enigma-like PDZ and LIM domains protein Antibody, L 9 Antibody, L9 Antibody, LIM Antibody, PDLI5_HUMAN An
Category:
Antibodies
Product Type:
Polyclonal Antibody
Immunogen:
A phospho-specific peptide corresponding to residues surrounding Tyr251 of human PDLIM5 (AA248-254)
Immunogen Species:
Human
Applications:
WB, AM
Host:
Rabbit
Isotype:
N/A
Species Reactivity:
Human
Antibody Dilution:
WB (1:250); optimal dilutions for assays should be determined by the user.
Purification:
Peptide Affinity Purified
Storage Buffer:
PBS pH7.4, 50% glycerol, 0.025% Thimerosal
Concentration:
N/A
Specificity:
Detects 64.002 kDa.
Storage:
-20ºC
Shipping:
Blue Ice or 4ºC
Certificate of Analysis:
A 1:250 dilution of SPC-1051 was sufficient for detection of PDLIM5 (pTyr251) in 10 µg of HeLa cell lysate by ECL immunoblot analysis using goat anti-rabbit IgG:HRP as the secondary antibody.
Highly expressed in heart and skeletal muscle. Expression is commonly increased in the brain of patients with bipolar disorder, schizophrenia, and major depression.
Alternative NameENH Antibody, ENH1 Antibody, Enigma homolog Antibody, Enigma like LIM domain protein Antibody, Enigma like PDZ and LIM domains protein Antibody, Enigma-like PDZ and LIM domains protein Antibody, L 9 Antibody, L9 Antibody, LIM Antibody, PDLI5_HUMAN An
CategoryAntibodies
Product TypePolyclonal Antibody
ImmunogenA phospho-specific peptide corresponding to residues surrounding Tyr251 of human PDLIM5 (AA248-254)
Immunogen SpeciesHuman
ApplicationsWB, AM
HostRabbit
IsotypeN/A
Species ReactivityHuman
Antibody DilutionWB (1:250); optimal dilutions for assays should be determined by the user.
Certificate of AnalysisA 1:250 dilution of SPC-1051 was sufficient for detection of PDLIM5 (pTyr251) in 10 µg of HeLa cell lysate by ECL immunoblot analysis using goat anti-rabbit IgG:HRP as the secondary antibody.
Tissue SpecificityHighly expressed in heart and skeletal muscle. Expression is commonly increased in the brain of patients with bipolar disorder, schizophrenia, and major depression.